BREAKING
Biomea Fusion 2025 Financial Report 37 minutes ago Absci Corporation 2025 Financial Update 46 minutes ago MaxCyte 2025 Financial Results Review 1 hour ago Braze Fiscal Year 2026 Financial Review 1 hour ago The Trade Desk, Inc. (TTD) Drops 6.6% to $22.36 16 hours ago Etsy, Inc. (ETSY) Drops 6.9% to $48.81 16 hours ago Core & Main, Inc. (CNM) Q4 Earnings: Misses on EPS, Revenue Recap 16 hours ago LFUS (LFUS) Jumps 6.0% to $349.99 16 hours ago HIMS (HIMS) Drops 5.9% to $21.13 17 hours ago BioAge Labs 2025 Financial Results Analysis 20 hours ago Biomea Fusion 2025 Financial Report 37 minutes ago Absci Corporation 2025 Financial Update 46 minutes ago MaxCyte 2025 Financial Results Review 1 hour ago Braze Fiscal Year 2026 Financial Review 1 hour ago The Trade Desk, Inc. (TTD) Drops 6.6% to $22.36 16 hours ago Etsy, Inc. (ETSY) Drops 6.9% to $48.81 16 hours ago Core & Main, Inc. (CNM) Q4 Earnings: Misses on EPS, Revenue Recap 16 hours ago LFUS (LFUS) Jumps 6.0% to $349.99 16 hours ago HIMS (HIMS) Drops 5.9% to $21.13 17 hours ago BioAge Labs 2025 Financial Results Analysis 20 hours ago
ADVERTISEMENT
AlphaGraphs

Infographic: Tilray reports narrower Q3 loss on higher revenues

Cannabis company Tilray, Inc. (NASDAQ: TLRY) Tuesday announced financial results for the third quarter of 2024, reporting a narrower net loss and double-digit revenue growth. The company reported a net loss of $105 million or $0.12 per share for the three months ended February 2024, compared to a loss of $1.20 billion or $1.90 per […]

April 9, 2024 1 min read

Cannabis company Tilray, Inc. (NASDAQ: TLRY) Tuesday announced financial results for the third quarter of 2024, reporting a narrower net loss and double-digit revenue growth. The company reported a net loss of $105 million or $0.12 per share for the three months ended February 2024, compared to a loss of $1.20 billion or $1.90 per […]

Cannabis company Tilray, Inc. (NASDAQ: TLRY) Tuesday announced financial results for the third quarter of 2024, reporting a narrower net loss and double-digit revenue growth.

Tilray Q3 2024 earnings infographic

The company reported a net loss of $105 million or $0.12 per share for the three months ended February 2024, compared to a loss of $1.20 billion or $1.90 per share in the prior year period. Adjusted cannabis gross profit decreased by 5% year-over-year to $21.1 million in Q3.

The improvement in bottom line performance reflects a 29% growth in third-quarter revenues to $188.3 million. At $10.2 million, adjusted EBITDA was down 23%.

ADVERTISEMENT